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Abstract
Cardiorespiratory fitness (CRF) has been documented as a strong, independent predictor of noncommunicable disease and mortality in both clinical and apparently healthy populations. This wellestablished relationship has impelled organizations, including the American Heart Association, to
release scientific statements highlighting the importance of accurate quantification of CRF. Current
knowledge of the relationship between CRF and mortality is predominantly based on estimated CRF
obtained from varying indirect methods. Cardiopulmonary exercise testing (CPX), the gold standard
method of CRF measurement, provides a more accurate and reliable quantification of CRF compared
to estimated methods. This review provides support for the diagnostic and prognostic use of CRF
based on the current literature and makes a case for the use of CPX when available, as well as the
need for standardization of normative values defining CRF levels to increase the efficacy of the risk
assessment. Further, clinical applications of CPX-derived CRF are discussed, providing clinicians
with recommendations on how to use and interpret this measure in practice to guide clinical decisions
and improve patient outcomes.
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Cardiorespiratory fitness (CRF) is related to
the integrated function of numerous
physiological systems, including the
circulatory, respiratory, and musculo-

skeletal, and thus is considered a reflection
of total body health1. Over the past three
decades, substantial evidence has emerged
supporting the value of CRF as a predictor

of
non-communicable
disease
and
premature mortality. The strong, inverse,
and independent relationship between CRF
and these adverse health outcomes has been
reported in several cohorts with varying
demographics and baseline health statuses,
speaking to its robustness as a diagnostic
and prognostic tool2-5. In fact, CRF has
been documented to be a stronger predictor
than other traditional risk factors 1, 3, 6. This
established relationship prompted the
American Heart Association (AHA) to
publish a scientific statement in 2016
promoting CRF as a clinical vital sign1.
Although the importance of CRF is wellestablished, several factors need to be
refined in order for CRF to be routinely and
effectively incorporated in clinical practice
(standardization, normative values defining
fitness levels, etc.). In this review, we
provide support for the diagnostic and
prognostic use of CRF based on the current
literature assessing the relationship between
CRF and health outcomes. We also discuss
clinical applications of CRF, providing
clinicians with recommendations on how to
use and interpret this measure in practice to
increase the efficacy of the risk assessment
and improve patient outcomes.
1.
Incorporating
Cardiorespiratory
Fitness into Practice: What Needs to be
Refined
The relationship between CRF and
mortality, when studied in apparently
healthy, disease free populations, has
almost exclusively been studied using
estimated CRF (CRFe). These estimates
were obtained from various indirect
methods, such as exercise workload or

duration on a maximal exercise test, 2, 3, 7, 8
heart rate at a submaximal workload 4, 8-11,
or more recently using non-exercise
prediction equations12-15. In 2009, Kodama
et al published a meta-analysis using data
from 33 studies to assess the quantitative
relationship of CRF with cardiovascular
disease (CVD) and all-cause mortality in
apparently healthy adults. Together these
studies utilized over 20 different methods
for obtaining CRF, including both direct
and indirect measurements 16. A more
recent paper by Harber et al reviewed the
research advances on this relationship since
2009. Data were reported from studies that
have utilized ~16 different CRF
measurement methods17. This highlights
the robust relationship between CRF and
health outcomes, but also underscores the
need of standardization.
Varying criteria used to define low CRF in
these research cohorts is also a concern, as
it presents challenges to clinicians’
interpretation18. Some defined CRF levels
by achievement of a specific metabolic
equivalent (MET), with the classification of
low CRF ranging from 4 to 9 METs for
exercise capacity 2, 19. Others use cohortspecific
CRF
classifications,
most
4, 9, 11
commonly tertiles (≤ 33%)
, quartiles
14, 20, 21
(≤25%)
, and quintiles (≤20%) 3, 12.
For example, Jensen et al 4 report <8.3
METs to represent low CRF in their cohort
of men, whereas the low CRF in the cohort
assessed by Park et al 9 corresponded to
≤6.3 METs. To add to the problem, the
majority of studies do not account for sex or
age in the defining criteria. However, it has
been clearly shown that CRF is influenced
by these factors, with men typically having
higher CRF values than women, and CRF

progressively decreasing with age in a nonlinear fashion 22. The varying methods used
to obtain CRFe, along with the differing
cohort specific criteria to define CRFe
levels, have led to inconsistencies between
studies in the degree of risk reduction
associated with each increment increase in
CRFe (8 to 35% risk reduction per MET
increment increase 1) and the magnitude of
protection associated with achieving higher
CRFe levels, all of which reduce
generalizability of past study results.
Kokkinos et al address this issue in a recent
report calling for standardization of CRF
categories to ameliorate methodological
discrepancies between studies18.
All methods used to predict CRF have
established estimation errors of ~1 to 2
METs. This would equate to an error of up
to 40% in those with low CRF (≤ 5
METs)23. This variability may result from
exercise-related factors including maximal
effort criteria, handrail use, protocol
selection, exercise mode, i.e. 24. Small
differences in CRF have been shown to
have important clinical application as
Kodama et al reported 1 MET increment
increase to be associated with 13 and 15%
reductions in risk for all-cause and CVD
mortality16, respectively. Therefore, the use
of CRFe has the potential to over- or
underestimate one’s risk for mortality by ~
30%.
Longitudinal studies have assessed the
influence of the change in CRF over time
(>4 years) on mortality risk, reporting
approximately 30 to 40% reduction in risk
by improving one’s CRF level from unfit to
fit 19, 25. However, similar to prior crosssectional studies, these longitudinal studies

used varying criteria to define fit and unfit
levels, and primarily used CRFe. This may
significantly impact the risk assessment, as
error may be introduced into both the
baseline and follow-up exercise tests, which
could lessen the sensitivity of the risk
stratification.
The findings from these longitudinal
analyses suggest that prescribing exercise to
increase CRF will improve longevity. Most
of these past studies did not directly assess
lifestyle changes between tests. CRF is
considered to be an objective measure of
physical activity (PA), and it has been
reported that 5 to 30% (1-2 MET)
improvements in CRF typically occur
following 3 to 6 months of an aerobic
exercise training program, with higher
improvements seen in those with lower
baseline CRF 23. The influence of posttraining improvements in CRFe on
prognosis has only been assessed in CVD
patients, showing a 30% reduction in allcause mortality per MET increase after 12
weeks of cardiac rehabilitation in patients
classified as low fit at baseline. Studies are
needed to assess the influence of short-term
improvements in CRF following initiation
of aerobic exercise training on mortality
risk in apparently healthy populations.
2. The Clinical Value of
pulmonary Exercise Testing

Cardio-

Cardiopulmonary exercise testing (CPX)
provides direct measurement of CRF,
expressed as maximal oxygen consumption
(VO2max), which minimizes the exercise
related factors that result in variability in
the estimated methods 24. For example, the
use of handrails when performing a

maximal exercise test without gas analysis
will increase exercise test duration and
allow the attainment of higher workloads
(ex. speed and/or grade), which would
result in a higher value of CRFe. As a direct
measurement of gas exchange, CPXderived CRF is not altered by handrail use,
increasing the accuracy and reliability, with
and
biological
variability
technical
estimated to be only ~3 to 4% 23. While
CPX has been historically underutilized due
to requirements for additional equipment
and trained personnel, these factors are no
longer significant barriers. Improvements in
technology and training, as well as the
growing awareness of its diagnostic and
prognostic value 26, 27 now allow CPX to be
considered for use more routinely in clinical
practice.
Hemodynamic responses to maximal
exercise testing, including heart rate
recovery and chronotropic incompetence
have also been shown to have prognostic
power. The prognostic value of these
measures is even more evident when
combined with CPX responses28, 29. CPX
can provide additional physiological
measurements that are valuable in
optimizing risk assessment in clinical
populations. These measurements include
minute ventilation (VE), ventilatory
threshold (VT), ventilatory efficiency
(VE/VCO2 slope), circulatory power,
exercise ventilatory power, exercise
oscillatory ventilation (EOV), partial
pressure of end-tidal carbon dioxide
(PETCO2), and oxygen uptake efficiency
slope (OUES)28. Guazzi et al describe the
scientific evidence behind the value of these
CPX
variables
in
their
2012
recommendations and the 2016 update 26, 27.

These scientific statements promote the use
of these emerging CPX variables to
increase
diagnostic
and
prognostic
sensitivity, as they allow for greater insight
into physiological factors that cause
functional limitations, potentially indicating
underlying disease1, 17, 22, 26. For example,
VE/VCO2 slope is a commonly used
prognostic measure with elevated VE/VCO2
slope values (≥34 indicating decreased
efficiency) associated with ventilationperfusion
abnormalities
commonly
experienced by heart failure, pulmonary
hypertension, and intrinsic lung disease
patients.
Patients’
prognosis
is
progressively worsened when VE/VCO2
becomes ≥40 28, 30, 31. Moreover, when heart
rate recovery is combined with VE/VCO2
slope, the multivariable score provides
clinicians with an integrated method that
powerfully predicts outcomes in cardiac
patients 29. Continued research is needed to
gain further insight into these emerging
CPX variables in order to increase the
evidence-base for their clinical value.
CPX-derived CRF has been used as a
diagnostic and prognostic tool in clinical
populations, with peak VO2 values < 20
ml/kg/min warranting strong consideration
of more aggressive medical treatment and
<10 ml/kg/min indicating particularly poor
prognosis. However, the use of CPX in
apparently healthy adults, free from medical
diagnosis of disease, is less established27.
To date, only one research cohort has
assessed the relationship between CPXderived CRF and all-cause and diseasespecific mortality in an apparently healthy
population. Laukkanen et al assessed the
association of CPX-derived CRF with
mortality outcomes in middle-aged men

from eastern Finland32-36. The results
showed 20%, 31%, 12%, and 23%
reductions in sudden cardiac death, CVD
mortality, cancer mortality, and all-cause
mortality, respectively 33, 36. Further, each
unit (ml/kg/min) change in CRF after 11
years was associated with a 9% reduction in
mortality risk in this cohort35. The use of
CPX-derived CRF make the findings from
this study promising, as they confirm the
well-established relationship between CRFe
and mortality, but the higher accuracy and
reliability of the method may improve the
risk assessment for mortality outcomes.
However, the generalizability of the results
beyond middle-aged Finnish men is
unknown. Therefore, research focusing on
the association of CPX-derived CRF with
clinical end-points, in diverse populations,
including both healthy women and men,
across a wide distribution of ages, ethnic
and racial groups, geographical locations,
and socioeconomic statuses is warranted.
The studies will help to more accurately
guide clinical decisions for these diverse
populations.
3. Clinical Application of
pulmonary Exercise Testing

Cardio-

The current literature suggests clinician
utilization of CPX would better predict
patient outcomes compared to estimated
methods. Currently, variability in physician
utilization and understanding of CRF may
be a limiting factor, even in a physician
office equipped with CPX equipment. The
Guazzi et al scientific statements provide
clear risk stratification algorithms, using
CPX evidence-based research results which
can provide guidance to clinicians for both

prognostic and diagnostic applications.
These statements also provide algorithms
specific to patient populations who are
healthy,
undergoing
a
pre-surgical
evaluation, or with underlying pulmonary
or cardiac abnormalities 26, 27.
Consequently, functional classification
beyond evaluation of clinical populations
(along with delineation of their unhealthy
habits) would suggest the need for two tiers
of disease- specific patients. The first
would be a functionally stable participant
for a rehabilitation program, with long term
follow-up testing. The second group
including patients in the pre-surgical or pretreatment (such as toxic chemotherapy)
phase, with their post-surgical or posttreatment outcome. The goal in this group
would be an eventual transition to a more
conventional rehabilitation program when
more
acute
goals
are
achieved.
Measurement of CPX-derived CRF in the
pre- and post-phases would provide a more
objective and accurate reflection of the
change in CRF in response to their overall
treatment, including lifestyle behavioral
modifications.
There remains a distinct discrepancy
between the value of CPX and a clinician’s
utilization of the service. Enthusiasm for
the ability to assess risk and detect
underlying disease based on clinical
variables obtained from CPX, as well as the
possibility to change a patient’s prognosis
by improving CRF through a fitness
program should herald a change in
physician interest. Previously, there was
high physician hesitation for ordering an
exercise test, out of their concern for patient
discomfort or anxiety. However, current

standard-of-care procedures can be more
intensive, while only providing risk
evaluation similar to CPX outcomes. A few
of these include cardiac stress tests with or
without intravenous catheter placement,
mammography, 24-hour gastric pH probes,
colonoscopies and esophagogastroscopy.
Therefore, the physician hesitations towards
the use of CPX should be reconsidered, as it
provides a wealth of clinical information
and significantly adds to the risk assessment
with minimal risk to the individual23.
The establishment of the Fitness Registry
and the Importance of Exercise National
Database, called for by the American Heart
Association in 2013, allows physicians to
more easily interpret non-communicable
disease and mortality risk based on CPX
derived CRF. This registry provides
population based age and sex-specific
reference values developed from > 12,000
CPX tests 22, 37, increasing generalizability
of CRF percentiles to the US adult
population that physicians see on a regular
basis. The use of CPX-derived CRF along
with age and sex-specific reference values
from the FRIEND registry would reduce
inconsistencies between studies and help
ease clinician interpretation of risk.
4. Conclusion
CRF has been shown to reflect total body
health and has important prognostic and
diagnostic value. Clinicians should assess
CRF routinely as a vital sign, which can
easily be done with CRFe methods. CPXderived CRF provides the most accurate
data, which will reduce misclassification of
risk, thus it should be increasingly
considered for use in clinical practice. A

wealth of clinical information is also
obtained through the measurement of CPX
variables which increase prognostic power
when
combined
with
CRF
and
hemodynamic measures. When used, CPXderived CRF can be interpreted with age
and sex-specific reference standards from
the FRIEND registry, which should help
guide clinical decisions. Those identified
with low CRF, via the routine CRF
assessments, should be recommended for
therapy (i.e. regular exercise training),
similar to how clinicians currently respond
by prescribing therapies for other CVD risk
factors.
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